Cimetidine Tablet, Film Coated
Product Images NDC 51655-697

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cimetidine (NDC 51655-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 697 51 Master Bottle Label Approval Rev A 03 21)

Label (51655 697 51 Master Bottle Label Approval   Rev A 03 21)
Label for Cimetidine Tablets, USP 400 mg film-coated tablets for oral use. The package contains 40 tablets and is labeled as Rx only. Storage instructions include keeping at 20°-25°C (68°-77°F), protecting from light, and keeping the container tightly closed. The label indicates it is repackaged by Northwind Pharmaceuticals Inc.*
FDA Label Image

Structural Formula (F45db833 Cec2 45d8 8b5f Ca1e820b8f48 01)

Structural Formula (F45db833 Cec2 45d8 8b5f Ca1e820b8f48 01)
Chemical structure of cimetidine, showing its molecular formula C10H16N6S and molecular weight 252.35. The diagram includes structural details of the compound's atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.